Search

Your search keyword '"Susman R"' showing total 102 results

Search Constraints

Start Over You searched for: Author "Susman R" Remove constraint Author: "Susman R"
102 results on '"Susman R"'

Search Results

1. DNA Mismatch Repair Gene Variant Classification: Evaluating the Utility of Somatic Mutations and Mismatch Repair Deficient Colonic Crypts and Endometrial Glands

2. A tumor focused approach to resolving the etiology of DNA mismatch repair deficient tumors classified as suspected Lynch syndrome.

3. Identifying primary and secondary MLH1 epimutation carriers displaying low-level constitutional MLH1 methylation using droplet digital PCR and genome-wide DNA methylation profiling of colorectal cancers

4. Evaluation of implementation of risk management guidelines for carriers of pathogenic variants in mismatch repair genes: a nationwide audit of familial cancer clinics

5. Implementing gene curation for hereditary cancer susceptibility in Australia: achieving consensus on genes with clinical utility.

7. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification.

8. Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers.

9. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification

10. Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations

11. Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers

12. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification

13. Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition (vol 118, pg 266, 2018)

14. Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition

15. Impact of national guidelines on use of BRCA1/2 germline testing, risk management advice given to women with pathogenic BRCA1/2 variants and uptake of advice.

16. Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition.

17. Psychological outcomes and surgical decisions after genetic testing in women newly diagnosed with breast cancer with and without a family history.

18. The ICCon familial cancer database.

19. Psychological outcomes and surgical decisions after genetic testing in women newly diagnosed with breast cancer with and without a family history

20. Bayesian approach to determining penetrance of pathogenic SDH variants

21. Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition (vol 118, pg 266, 2018)

22. Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition

23. Evaluation of implementation of risk management guidelines for carriers of pathogenic variants in mismatch repair genes: a nationwide audit of familial cancer clinics.

24. Streamlined genetic education is effective in preparing women newly diagnosed with breast cancer for decision making about treatment-focused genetic testing: A randomized controlled noninferiority trial.

25. Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study

26. A phase 2/3, multicenter, randomized, double-masked, 2-year trial of pegaptanib sodium for the treatment of diabetic macular edema

27. Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study

28. Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: Results from the initial screening round of the IMPACT study.

29. Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: Results from the initial screening round of the IMPACT study

30. How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer.

33. The functional morphology of the accessory interosseous muscle in the gibbon hand: determination of locomotor and manipulatory compromises

35. Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study

36. Cancer Risks Associated With TP53 Pathogenic Variants: Maximum Likelihood Analysis of Extended Pedigrees for Diagnosis of First Cancers Beyond the Li-Fraumeni Syndrome Spectrum.

37. Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41.

38. DNA Mismatch Repair Gene Variant Classification: Evaluating the Utility of Somatic Mutations and Mismatch Repair Deficient Colonic Crypts and Endometrial Glands.

39. Identifying primary and secondary MLH1 epimutation carriers displaying low-level constitutional MLH1 methylation using droplet digital PCR and genome-wide DNA methylation profiling of colorectal cancers.

40. A tumor focused approach to resolving the etiology of DNA mismatch repair deficient tumors classified as suspected Lynch syndrome.

41. Implementing gene curation for hereditary cancer susceptibility in Australia: achieving consensus on genes with clinical utility.

42. Birt-Hogg-Dubé Syndrome and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome: An Effective Multidisciplinary Approach to Hereditary Renal Cancer Predisposing Syndromes.

43. RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML.

44. Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers.

45. Spectrum of gastrointestinal tract pathology in a multicenter cohort of 43 Cowden syndrome patients.

46. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification.

47. The association between multiple pilomatrixomas and APC gene mutations.

48. Bayesian approach to determining penetrance of pathogenic SDH variants.

49. Psychological outcomes and surgical decisions after genetic testing in women newly diagnosed with breast cancer with and without a family history.

50. Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition.

Catalog

Books, media, physical & digital resources